Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × cc-486 × Clear all

NCT02900560 2022-06-10

Study of Pembrolizumab With or Without CC-486 in Patients With Platinum-resistant Ovarian Cancer

Phase 2 Terminated

34 enrolled 15 charts

Carcinoma, Ovarian Epithelial